Health Catalyst Stock Price, News & Analysis

Healthmine, a member engagement and rewards platform for health plans, has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine, with over 25 years of healthcare technology experience, succeeds Bryce Williams, who will transition to an advisory role.

Prior to joining Healthmine, Erskine served as Senior Vice President of Enterprise Transformation at VillageMD and healthcare leader at Synergetics. Under his leadership, Healthmine aims to expand its technology and strengthen partnerships. The company has already achieved significant milestones in 2025, including launching AI-supported patient scheduling, improved in-home assessment connectivity, and strategic partnerships with Exact Sciences and Tenasol.

Health Catalyst (NASDAQ:HCAT) has appointed Ben Albert as President and Chief Operating Officer. Albert, who previously served as CEO & Co-Founder of Upfront Healthcare Services until its acquisition by Health Catalyst, brings over 25 years of healthcare leadership experience.

This appointment comes as current CEO Dan Burton prepares for his previously announced retirement in June 2026. Albert will oversee day-to-day operations with senior leaders in Product Engineering, Technology Delivery and Support, Growth, Operations, Finance, and Corporate Strategy reporting to him. Additionally, Dan LeSueur will transition from his full-time role to a part-time advisory position supporting the leadership transition.

Health Catalyst (NASDAQ:HCAT) has expanded its partnership with CyncHealth Nebraska, the state's health information exchange (HIE), to enhance the delivery of Continuity of Care Documents (CCDs). The collaboration will leverage Health Catalyst's Ninja Universe technology, an advanced parsing tool designed to improve healthcare data exchange.

The partnership aims to provide more accurate, timely, and secure patient health information sharing across Nebraska's healthcare systems. This initiative will support clinical decision-making and care coordination by streamlining how CCDs are parsed and shared throughout the HIE network.

Health Catalyst (NASDAQ:HCAT) announced the winners of its 2025 Catalyst Awards at the Health Catalyst Analytics Summit in Salt Lake City. The awards recognized 28 healthcare organizations for excellence in data-driven healthcare transformation across five categories.

Key winners include: Lifepoint Health for Care Quality Excellence, saving 700+ lives through improved sepsis care; Temple University Health System for Financial Transformation, generating millions in revenue through activity-based costing; Revere Medical for Quality Performance, achieving significant improvements in patient care metrics; INTEGRIS Health for Organizational Transformation, securing $32.7 million in combined cost savings; and Innovative Healthcare Collaborative of Indiana for Population Health Impact, achieving $28.3 million in cost reductions.

Health Catalyst (Nasdaq: HCAT) has launched Upfront Market Insights on Salesforce AppExchange, enhancing healthcare organizations' ability to engage with patients through data-driven insights. The integration works seamlessly with Salesforce Health Cloud and Marketing Cloud, enabling healthcare providers to leverage advanced personalization features without additional tools or staff.

The solution allows healthcare enterprises to segment contact lists based on psychographics and create targeted patient journeys with personalized content. This integration aims to improve patient engagement in critical screenings, treatments, and healthcare resources through better understanding of patient populations and their unique motivators.

Health Catalyst (NASDAQ: HCAT), a leading healthcare data and analytics technology provider, has announced its participation in three major upcoming investor conferences in September 2025:

• Cantor Global Healthcare Conference in New York on September 3, 2025 at 9:10 AM ET
• Wells Fargo Healthcare Conference in Boston on September 4, 2025 at 1:30 PM ET
• Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 9, 2025 at 11:30 AM ET

Senior management, including CEO Dan Burton, CFO Jason Alger, and SVP of Finance Matt Hopper, will participate in fireside chats at these events. Webcasts will be available on the company's investor relations website.

Health Catalyst (NASDAQ: HCAT) announced that CEO Dan Burton will step down from his position effective June 30, 2026, to pursue volunteer service opportunities with his wife in support of their faith. Burton, who has led the company for 15 years, will continue to serve on the Board and support the search for a new CEO.

Under Burton's leadership, Health Catalyst grew from a 3-person team to a public company with 1,100 healthcare clients and 1,400 team members. The company achieved over $2.2 billion in client-approved improvements and maintained exceptional team member engagement levels between the 94th and 99th percentile over the past decade, earning more than 125 Best Workplace Awards since 2013.

Health Catalyst (Nasdaq: HCAT) reported strong Q2 2025 financial results, with total revenue of $80.7 million (up 6% YoY) and Adjusted EBITDA of $9.3 million (up 24% YoY), exceeding quarterly guidance. The company maintained a gross margin of 38% and an Adjusted Gross Margin of 50%.

CEO Dan Burton announced his planned retirement effective June 30, 2026, after 15 years of leadership. The Board will conduct a CEO search, with Burton continuing to serve on the Board post-retirement.

For Q3 2025, Health Catalyst expects revenue of approximately $75 million and Adjusted EBITDA of $10.5 million. Full-year 2025 guidance projects revenue of $310 million and Adjusted EBITDA of $41 million.

Health Catalyst (NASDAQ: HCAT), a leading healthcare data and analytics technology provider, has scheduled its second quarter 2025 earnings release for Thursday, August 7, 2025, after market close.

The company will host a conference call at 5:00 PM ET on the same day. U.S. participants can dial 800-343-5172, while international participants should call 203-518-9856 using conference ID "HCATQ225". A live webcast will be available at ir.healthcatalyst.com, with a replay accessible for approximately 90 days.